Alessandro Maria Vannucchi

Full Professor of Hematology, founder of the Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM) and currently Director of the Hematology Department and Director of Oncology Department at University of Florence and Azienda Ospedaliera Universitaria Careggi. 

He holds various appointments at the University of Florence, including Director of the Postgraduate School in Hematology. He currently serves as the Chair of the European LeukemiaNet Work Package 9 and the GIMEMA Foundation Working Party on MPN, and is the principal investigator of the Italian MyNERVA research alliance on MPN and related myeloid disorders. He sits on the board of the International Working Group for Myelofibrosis Research and Treatment (IWG-MRT), the European Hematology Association Specialized Working Group on Myeloproliferative Neoplasms. He is currently the President of the Italian Society of Experimental Hematology. 

His main research interests are the myeloproliferative neoplasms (MPNs) and molecular genetics of myeloid neoplasia, including leukemias. He is/has been the PI of more than 70 clinical trials. Dr Vannucchi has authored and co-authored more than 720 peer-reviewed publications, mostly in the field of MPN, and presented communications and invited lectures at national and international meetings In 2024, he received an Award for „Scientific Achievements in MPN“ at the New York Annual MPN meeting. Since 2017, he is listed among the „Highly Cited Researchers „in Clinical Medicine – Web of Science, „Highly Ranked ScholarGPS“, and the „100-top Italian Scientists“. 

In 2023, he received the honor of Commander of Merit by the President of the Republic of Italy, Honorable President Sergio Mattarella, for his scientific achievements.

ORCID ID: https://orcid.org/0000-0001-5755-0730